Lindsey A. George, MD

Lindsey A. George, MD

Lindsey A. George, MD, is an attending physician in the Division of Hematology at The Children's Hospital of Philadelphia.

Areas of Expertise: Hemostasis and thrombosis disorders, Hemophilia gene therapy, Hemophilia
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training

Medical School

MD - State University of New York School of Medicine at Buffalo, Buffalo, NY

Residency

Pediatrics - Weill Cornell Medical College New York, NY (Chief Resident)

Fellowship

Pediatric Hematology/Oncology - The Children’s Hospital of Philadelphia, Philadelphia, PA

Board Certification

American Board of Pediatrics

Titles and Academic Titles

Attending Physician

Instructor, Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania

Departments and Services

Publications

Papers

2015

George LA, Thalji NK, Cronin MN, Raffini LJ, Camire RM. A new bypass strategy: zymogen-like Factor XaI16L corrects Hemophilia A whole blood thromboelastometry findings. J Thromb Haemost 2015;13(9):1694-8. [PMID 26190406]

2014

Greene LA, Chen S, Seery C, Imahiyerobo AM, Bussel JB. Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia (ITP). B J Haematol 2014; 166: 592-600. [PMID 24797389]

Greene LA, Law C, Jung M, Walton S, Ignjatovic V, Monagle P, Raffini LJ. Lack of anti-Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 2014; 12:1-4. [PMID 24943261]

2013

Greene LA, Goldenberg NA, Simpson ML, Villalobos-Menuery E, Bombardier C, Acharya SS, Santiago-Berrero PJ, Cambara A, DiMichele DM. Use of global assays to understand phenotype in congenital Factor VII deficiency. Haemophilia 2013; 19(5): 765-72. [PMID 23682803]

Posters and Presentations

2015

Greene LA, Thalji NK, Bradford HL, Krishnaswamy S, Camire RM. Zymogen-like FXa variant as novel warfarin reversal strategy: Pre-clinical evaluation and mechanism of action. International Society of Thrombosis and Hemostasis Meeting 2015

Greene LA, Thalji NK, Bradford HL, Krishnaswamy S, Camire RM. Prothrombin Membrane Binding And Gla-Dependent Function Are Not Required for Effective Hemostasis In Vivo, American Society of Hematology Meeting 2015

2014

Greene LA, Thalji NK, Cronin MN, Raffini LJ, Camire RM. A new bypass strategy: zymogenlike Factor XaI16L corrects Hemophilia A whole blood thromboelastometry findings. Thrombosis and Hemostasis Society of North America Meeting 2014

Greene LA, Thalji NK, Raffini LJ, Camire RM. Zymogen-like FXa variant as a short-acting warfarin reversal agent: Pre-clinical evaluation and mechanism of action. American Society of Hematology Meeting 2014

2013

Greene LA, Law C, Jung M, Walton S, Ignjatovic V, Monagle P, Raffini LJ. Lack of anti-Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. American Society of Hematology Meeting 2013

Awards and Honors

2015 - Best Oral Abstract Presentation, Philadelphia Workshop in Thrombosis and Hemostasis,
Philadelphia, PA
2015 - Young Investigator Award, International Society of Thrombosis and Hemostasis, Toronto,
CA
2014 - Outstanding Abstract, Thrombosis and Hemostasis Society of North America, Chicago, IL
2014 - Future Leaders in Hematology, Celgene Biopharmaceuticals, Anaheim, CA
2013 - Abstract Achievement Award, American Society of Hematology, New Orleans, LA

 

Editorial and Academic Positions

Editorial positions

Ad-hoc reviewer

Haemophilia
Thrombosis Research
Haematologica

Leadership and Memberships

Memberships in Professional Organizations

2010-present Member, American Society of Hematology
2013-present Member, International Society of Thrombosis and Haemostasis